M. TERESA CEDENA ROMERO-rekin lankidetzan egindako argitalpenak (2)

2021

  1. Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma

    Journal of Hematology and Oncology

2020

  1. Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma

    Blood Advances, Vol. 4, Núm. 10, pp. 2163-2171